Back to Selection     Print       Date : 31 Mar 2025
Fund Summary
UTI Healthcare Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Jun-1999
Corpus(Cr.) 1042.0 Latest NAV 276.6098 As on 30-05-2025
Equity(%) 99.2 52 Week High 295.297
Debt(%) 0.8 52 Week Low 219.587
Others(%) 0.0 Exit Load 1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.25
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Kamal Gada
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 30.28%
Top 10 Holdings 46.71%
Top 25 Holdings 80.65%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 73.54
Healthcare 24.44
Communication 1.22
Cash 0.79
Others 0.01
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.52
PE Ratio 31.72
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 11.65
Cipla Limited 5.81
Ajanta Pharma Limited 4.40
Dr Reddys Laboratories Limited 4.35
Glenmark Pharmaceuticals Limited 4.07
Procter & Gamble Health Limited 3.65
Apollo Hospitals Enterprise Limited 3.57
Fortis Health Care Ltd 3.12
DIVI LABORATORIES LTD 3.10
Alkem Laboratories Limited 2.99
Suven Pharmaceuticals Limited 2.97
Krishna Inst of Medical Sciences Ltd. 2.95
Eris Lifesciences Limited 2.90
Aurobindo Pharma Limited 2.78
Gland Pharma Limited 2.75
Caplin Point Laboratories Limited 2.35
Lupin Limited 2.34
Aster DM Healthcare Limited 2.27
Zydus Lifesciences Limited 2.13
Max Healthcare Institute Limited 2.01
EQ- GLOBAL HEALTH LTD. 1.91
Torrent Pharmaceuticals Limited 1.83
EQ- JUPITER LIFE LINE HOSPITALS LTD 1.72
WINDLAS BIOTEC LTD 1.53
Metropolis Healthcare Limited 1.50

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
2.38% 11.46% -3.83% 23.96%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.92% 12.13% 3.05% 11.08%
 
Scheme Benchmark [BSE Healthcare TRI]
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
35.01% 24.22% 21.80% 11.14%
 
 
16.89% 15.56% 22.29% 12.73%
 
 
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
UTI Healthcare Fund (G) 16.70% -0.6627 14.7120% 47.1545 -0.0331
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
UTI Healthcare Fund (G) -12.4772% 0.7528 -0.1697 15.3925 -1.1300
 
Back to Selection